Avid Bioservices Inc (CDMO)

[eastcoastguy]

The RS was pretty much a lock once Sunrise was terminated. Our capital structure is bloated and needs trimming. We'll have 40-50M shares OS after the RS. 2-3 a share with a MC of 85-120M. Probably what AVID is worth in 2017. Once Sunrise was ended research/development was outsourced to MSK and NCCN to limit the burn rate.

Announcement of RS brings on a lot of emotional venting. Yes we all wanted Sunrise to succeed and our shares to be worth 10-20/share. But that's not happening. AVID is the life raft while the company gets right sized and hopefully someone finds a use for Bavituximab.

In the meantime PPHM licensed Exosome based cancer detection tech from UT Southwestern Medical. If PPHM was such a fraud do you really think they'd be able to enter into another license with UT? I know we all want to throw the bums out but we didn't hear all this when Sunrise was streaming along and dollars were dancing in everyone's head. Sunrise failed, it stinks, we have too many shares and now we have to right size. It's a race to get AVID profitable and hopefully monetize all these licenses and patents.

I'm sure DART, and our new investor Kennedy Capital Management know the game plan. If (and it's a big if) there's promise for BAVI then institutions will want in and retail has to go. Not happy with the RS but I've been in since 2004 and will stick around to see the final chapter.

There's little rope left for PPHM. I think they know it.

best to all,
eastcoastguy